Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
BackgroundDevelopment of a core outcome set (COS) for clinical trials for COVID-19 is urgent because of the pandemic wreaking havoc worldwide and the heterogeneity of outcomes in clinical trials.MethodsA preliminary list of outcomes was developed after a systematic review of protocols of clinical tr...
Main Authors: | Ruijin Qiu, Chen Zhao, Tengxiao Liang, Xuezeng Hao, Ya Huang, Xiaoyu Zhang, Zhao Chen, Xuxu Wei, Mengzhu Zhao, Changming Zhong, Jiayuan Hu, Min Li, Songjie Han, Tianmai He, Yang Sun, Jing Chen, Hongcai Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00781/full |
Similar Items
-
Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol
by: Ruijin Qiu, et al.
Published: (2018-10-01) -
Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol
by: Ruijin Qiu, et al.
Published: (2021-05-01) -
Multidisciplinary integration to enhance the overall level of Chinese and Western medicine consensus efficacy
by: Hong-Cai Shang, et al.
Published: (2017-04-01) -
Thinking on the development of clinical integrated traditional Chinese and Western medicine nursing
by: CHEN Hong, et al.
Published: (2021-03-01) -
Advances of Chinese and Western Medicine on Rheumatoid Arthritis
by: Na-na HE, et al.
Published: (2015-03-01)